You are here

Asia-Pacific Lung Transplant Therapeutics Market Industry Trends and Forecast to 2029

Asia-Pacific Lung Transplant Therapeutics Market Analysis and Size

The Asia-Pacific lung transplant therapeutics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 3.2% in the forecast period of 2022 to 2029 and is expected to reach USD 31.89 million by 2029. The launch of new products by major market players is expected to drive the market's demand in the forecast period.

REPORT METRICDETAILSForecast Period2023 to 2039Base Year2021Historic Years2020 (Customizable to 2019 - 2014)Quantitative UnitsRevenue in USD MillionCountry CoveredJapan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Vietnam, Indonesia, the Philippines, and the Rest of Asia-Pacific.Market Players CoveredApotex Inc, Bridge to Life Ltd, Intas Pharmaceuticals Ltd., Viatris Inc., Pfizer Inc., F.Hoffmann-La Roche Ltd., Panacea Biotec Ltd., Astellas Pharma Inc., Accord-UK Ltd, Novartis AG, Hikma Pharmaceuticals PLC, Detraxi Inc, Dr. Reddy's Laboratories Ltd., among others.

Request Access for Sample Report:-

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pac...

Asia-Pacific Lung Transplant Therapeutics Market Scope

On the basis of product, the global Asia-Pacific Lung Transplant Therapeutics Market is segmented into immunosuppressant drugs, tissue products, organ preservation products, and others. In 2022, the immunosuppressant drugs segment is expected to dominate the global Asia-Pacific Lung Transplant Therapeutics Market due to the increase in the consumption of immune system suppressant drugs because of their wider benefit and effective profile by patients to avoid lung rejection and the wide availability of these drugs in hospitals and retail stores.

On the basis of type, the global Asia-Pacific Lung Transplant Therapeutics Market is segmented into cadaveric lung transplantation and living lung transplantation. In 2022, the cadaveric lung transplantation segment is expected to dominate the global Asia-Pacific Lung Transplant Therapeutics Market due to increased awareness regarding organ donation and its applications.

On the basis of indication, the global Asia-Pacific Lung Transplant Therapeutics Market is segmented into chronic obstructive pulmonary diseases (COPD), pulmonary fibrosis, septic lung disease, pulmonary hypertension, cystic fibrosis, interstitial pulmonary fibrosis, emphysema, primary pulmonary arterial hypertension sarcoidosis, and others. In 2022, the cystic fibrosis segment is expected to dominate the global Asia-Pacific Lung Transplant Therapeutics Market due to the increase in the patient population of cystic fibrosis patients in the region.

On the basis of technique, the global Asia-Pacific Lung Transplant Therapeutics Market is segmented into single-lung transplantation, bilateral-lung transplantation, heart-lung transplantation, and double lung transplantation. In 2022, the single-lung transplantation (SLT) segment is expected to dominate the global Asia-Pacific Lung Transplant Therapeutics Market due to the highest number of lung transplantation procedures in North America (55%) and Europe (36%).

On the basis of patient demographics, the global Asia-Pacific Lung Transplant Therapeutics Market is segmented into adult, pediatric, and geriatric. In 2022, the adult segment is expected to dominate the global Asia-Pacific Lung Transplant Therapeutics Market due to the increase in health complications observed in the world population, China and India of the Asia-Pacific region contributes the largest population.

On the basis of end users, the global Asia-Pacific Lung Transplant Therapeutics Market is segmented into hospital, transplant centers, specialty centers, and others. In 2022, the hospital segment is expected to dominate the global Asia-Pacific Lung Transplant Therapeutics Market due to new hospital advancements for effective surgeries under-skilled doctors and increased awareness regarding organ donation, registration, and chronic diseases.

Access Full Report:-

https://www.databridgemarketresearch.com/reports/asia-pacific-lung-trans...

Major TOC of the Report

1 INTRODUCTION

2 MARKET SEGMENTATION

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

Get TOC of the Report:-  

https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-lung-tra...

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgeMarketresearch.com

Browse Related Reports@

Discrete Semiconductor Market – Industry Trends and Forecast to 2029

Medical Spa Market – Industry Trends and Forecast to 2030

Stainless Steel Market – Industry Trends and Forecast to 2029